Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 2416 AL 2430

Device profile of the percept PC deep brain stimulation system for the treatment of Parkinson's disease and related disorders

Jimenez-Shahed J.

Expert Rev Med Devices. 2021 Apr;18(4):319-332. doi: 10.1080/17434440.2021.1909471. Epub 2021 Apr 5.

Impact of subthreshold depression on health-related quality of life in patients with Parkinson's disease based on cognitive status

Schönenberg A, Zipprich HM, Teschner U, Grosskreutz J, Witte OW, Prell T.

Health Qual Life Outcomes. 2021 Mar 25;19(1):107. doi: 10.1186/s12955-021-01753-5.

Trans-Spinal Direct Current Stimulation for Managing Primary Orthostatic Tremor

Lamy JC, Varriale P, Apartis E, Mehdi S, Blancher-Meinadier A, Kosutzka Z, Degos B, Frismand S, Simonetta-Moreau M, Meunier S, Roze E, Vidailhet M.

Mov Disord. 2021 Aug;36(8):1835-1842. doi: 10.1002/mds.28581. Epub 2021 Mar 27.

Movement disorder surgery Part I: historical background and principle of surgery

Yap Y, Morris R, Adapa R.

BJA Educ. 2021 Apr;21(4):133-139. doi: 10.1016/j.bjae.2020.11.008. Epub 2021 Jan 21.

Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA-FLUO Trial

Rascol O, Cochen de Cock V, Pavy-Le Traon A, Foubert-Samier A, Thalamas C, Sommet A, Rousseau V, Perez-Lloret S, Fabbri M, Azulay JP, Corvol JC, Couratier P, Damier P, Defebvre L, Durif F, Geny C, Houeto JL, Remy P, Tranchant C, Verin M, Tison F, Meissner WG; MSA-FLUO Study Group.

Mov Disord. 2021 Jul;36(7):1704-1711. doi: 10.1002/mds.28569. Epub 2021 Apr 1.

Translating Evidence to Advanced Parkinson's Disease Patients: A Systematic Review and Meta-Analysis

Nijhuis FAP, Esselink R, de Bie RMA, Groenewoud H, Bloem BR, Post B, Meinders MJ.

Mov Disord. 2021 Jun;36(6):1293-1307. doi: 10.1002/mds.28599. Epub 2021 Apr 2.

Neuroticism and Risk of Parkinson's Disease: A Meta-Analysis

Terracciano A, Aschwanden D, Stephan Y, Cerasa A, Passamonti L, Toschi N, Sutin AR.

Mov Disord. 2021 Aug;36(8):1863-1870. doi: 10.1002/mds.28575. Epub 2021 Apr 4.

Neurodegeneration: Impact of S-nitrosylated Parkin, DJ-1 and PINK1 on the pathogenesis of Parkinson's disease

Sircar E, Rai SR, Wilson MA, Schlossmacher MG, Sengupta R.

Arch Biochem Biophys. 2021 Jun 15;704:108869. doi: 10.1016/j.abb.2021.108869. Epub 2021 Apr 2.

The Neurophysiology of Sleep in Parkinson's Disease

Zahed H, Zuzuarregui JRP, Gilron R, Denison T, Starr PA, Little S.

Mov Disord. 2021 Jul;36(7):1526-1542. doi: 10.1002/mds.28562. Epub 2021 Apr 7.

Trimetazidine Use in Parkinson's Disease: Is It a Resolved Problem?

Pintér D, Bereczki D, Ajtay A, Oberfrank F, Janszky J, Kovács N.

eNeuro. 2021 May 19;8(3):ENEURO.0452-20.2021. doi: 10.1523/ENEURO.0452-20.2021. Print 2021 May-Jun.

Functional Improvement of Tacrolimus-Induced Parkinsonism With Amantadine After Liver Transplantation: A Case Report

Diaz-Segarra N, Edmond A, Yonclas P.

Clin Neuropharmacol. 2021 Jul-Aug 01;44(4):141-144. doi: 10.1097/WNF.0000000000000444.

Prodromal Parkinson disease subtypes - key to understanding heterogeneity

Berg D, Borghammer P, Fereshtehnejad SM, Heinzel S, Horsager J, Schaeffer E, Postuma RB.

Nat Rev Neurol. 2021 Jun;17(6):349-361. doi: 10.1038/s41582-021-00486-9. Epub 2021 Apr 20.

SARS-CoV-2-related encephalitis with prominent parkinsonism: clinical and FDG-PET correlates in two patients

Morassi M, Palmerini F, Nici S, Magni E, Savelli G, Guerra UP, Chieregato M, Morbelli S, Vogrig A.

J Neurol. 2021 Nov;268(11):3980-3987. doi: 10.1007/s00415-021-10560-3. Epub 2021 Apr 21.

Genetic Modifiers of Age at Onset for Parkinson's Disease in Asians: A Genome-Wide Association Study

Li C, Ou R, Chen Y, Gu X, Wei Q, Cao B, Zhang L, Hou Y, Liu K, Chen X, Song W, Zhao B, Wu Y, Li T, Dong X, Shang H.

Mov Disord. 2021 Sep;36(9):2077-2084. doi: 10.1002/mds.28621. Epub 2021 Apr 21.

Nuclear factor-kappa B (NF-κB) in pathophysiology of Parkinson disease: Diverse patterns and mechanisms contributing to neurodegeneration

Dolatshahi M, Ranjbar Hameghavandi MH, Sabahi M, Rostamkhani S.

Eur J Neurosci. 2021 Apr 21. doi: 10.1111/ejn.15242. Online ahead of print.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias